MATINAS BIOPHARMA HOLDINGS, INC. Research and Development Expense
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Research and Development Expense of $85.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. research and development expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. research and development expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. research and development expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. research and development expense for the quarter ending 2025-03-31 was $85.00K, a 97.53% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. research and development expense for fiscal 2025 was $85.00K, a 99.26% decline from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. research and development expense for fiscal 2024 was $11.43M, a 21.09% decline from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. research and development expense for fiscal 2023 was $14.49M, a 13.13% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. research and development expense for fiscal 2022 was $16.68M, a 14.37% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 32 month |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $85.00K 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $85.00K 10-Q · filed 2025-11-10 | $2.46M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $85.00K 10-Q · filed 2026-08-13 | $2.46M derived: sum of 3 quarters · filed 2026-08-13 | $4.70M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $85.00K 10-Q · filed 2026-05-08 | $2.46M derived: sum of 2 quarters · filed 2026-05-08 | $4.70M derived: sum of 3 quarters · filed 2026-05-08 | $8.07M derived: sum of 4 quarters · filed 2026-05-08 | |||||
| 2024-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.62M derived: sum of 2 quarters · filed 2026-03-31 | $7.99M derived: sum of 3 quarters · filed 2026-03-31 | $11.43M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $2.24M 10-Q · filed 2025-11-10 | $5.61M derived: sum of 2 quarters · filed 2025-11-10 | $9.06M 10-Q · filed 2025-11-10 | $12.72M derived: sum of 4 quarters · filed 2025-11-10 | |||||
| 2024-06-30 | $3.37M 10-Q · filed 2025-08-14 | $6.82M 10-Q · filed 2025-08-14 | $10.48M derived: sum of 3 quarters · filed 2025-08-14 | $13.78M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $3.45M 10-Q · filed 2025-05-15 | $7.11M derived: sum of 2 quarters · filed 2025-05-15 | $10.41M derived: sum of 3 quarters · filed 2025-05-15 | $13.96M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $6.96M derived: sum of 2 quarters · filed 2025-04-15 | $10.52M derived: sum of 3 quarters · filed 2025-04-15 | $14.49M 10-K · filed 2025-04-15 | |||||
| 2023-09-30 | $3.29M 10-Q · filed 2024-11-13 | $6.85M derived: sum of 2 quarters · filed 2024-11-13 | $10.82M 10-Q · filed 2024-11-13 | $14.69M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $3.56M 10-Q · filed 2024-08-14 | $7.53M 10-Q · filed 2024-08-14 | $11.40M derived: sum of 3 quarters · filed 2024-08-14 | $15.10M derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | $3.97M 10-Q · filed 2024-05-09 | $7.84M derived: sum of 2 quarters · filed 2024-05-09 | $11.54M derived: sum of 3 quarters · filed 2024-05-09 | $15.67M derived: sum of 4 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $7.57M derived: sum of 2 quarters · filed 2024-03-27 | $11.70M derived: sum of 3 quarters · filed 2024-03-27 | $16.68M 10-K · filed 2024-03-27 | |||||
| 2022-09-30 | $3.71M 10-Q · filed 2023-11-08 | $3.71M 10-Q · filed 2022-11-02 | $7.83M derived: sum of 2 quarters · filed 2023-11-08 | $12.81M 10-Q · filed 2023-11-08 | $12.81M 10-Q · filed 2022-11-02 | $17.05M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $4.13M 10-Q · filed 2023-08-09 | $4.13M 10-Q · filed 2022-08-11 | $9.11M 10-Q · filed 2023-08-09 | $9.10M 10-Q · filed 2022-08-11 | $13.34M derived: sum of 3 quarters · filed 2023-08-09 | $17.97M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $4.98M 10-Q · filed 2023-05-10 | $4.98M 10-Q · filed 2022-05-12 | $9.22M derived: sum of 2 quarters · filed 2023-05-10 | $13.84M derived: sum of 3 quarters · filed 2023-05-10 | $16.32M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $8.86M derived: sum of 2 quarters · filed 2023-03-15 | $11.34M derived: sum of 3 quarters · filed 2023-03-15 | $14.58M 10-K · filed 2023-03-15 | $14.58M 10-K · filed 2022-03-08 | ||||
| 2021-09-30 | $4.62M 10-Q · filed 2022-11-02 | $7.10M derived: sum of 2 quarters · filed 2022-11-02 | $10.34M 10-Q · filed 2022-11-02 | $13.87M derived: sum of 4 quarters · filed 2022-11-02 | |||||
| 2021-06-30 | $2.48M 10-Q · filed 2022-08-11 | $5.72M 10-Q · filed 2022-08-11 | $9.25M derived: sum of 3 quarters · filed 2022-08-11 | $12.58M derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | $3.24M 10-Q · filed 2022-05-12 | $6.77M derived: sum of 2 quarters · filed 2022-05-12 | $10.10M derived: sum of 3 quarters · filed 2022-05-12 | $13.51M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $3.53M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $6.86M derived: sum of 2 quarters · filed 2022-03-11 | $10.27M derived: sum of 3 quarters · filed 2022-03-11 | $14.36M 10-K/A · filed 2022-03-11 | |||||
| 2020-09-30 | $3.34M 10-Q · filed 2021-11-08 | $6.75M derived: sum of 2 quarters · filed 2021-11-08 | $10.83M 10-Q · filed 2021-11-08 | $14.25M derived: sum of 4 quarters · filed 2021-11-08 | |||||
| 2020-06-30 | $3.41M 10-Q · filed 2021-08-10 | $7.50M 10-Q · filed 2021-08-10 | $10.92M derived: sum of 3 quarters · filed 2021-08-10 | $13.59M derived: sum of 4 quarters · filed 2021-08-10 | |||||
| 2020-03-31 | $4.09M 10-Q · filed 2021-05-10 | $7.51M derived: sum of 2 quarters · filed 2021-05-10 | $10.18M derived: sum of 3 quarters · filed 2021-05-10 | $13.01M derived: sum of 4 quarters · filed 2021-05-10 | |||||
| 2019-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $6.09M derived: sum of 2 quarters · filed 2021-03-29 | $8.92M derived: sum of 3 quarters · filed 2021-03-29 | $11.23M 10-K · filed 2021-03-29 | |||||
| 2019-09-30 | $2.67M 10-Q · filed 2020-11-06 | $5.50M derived: sum of 2 quarters · filed 2020-11-06 | $7.81M 10-Q · filed 2020-11-06 | $9.51M derived: sum of 4 quarters · filed 2020-11-06 | |||||
| 2019-06-30 | $2.83M 10-Q · filed 2020-08-10 | $5.14M 10-Q · filed 2020-08-10 | $6.84M derived: sum of 3 quarters · filed 2020-08-10 | $8.22M derived: sum of 4 quarters · filed 2020-08-10 | |||||
| 2019-03-31 | $2.31M 10-Q · filed 2020-05-11 | $4.01M derived: sum of 2 quarters · filed 2020-05-11 | $5.39M derived: sum of 3 quarters · filed 2020-05-11 | $6.91M derived: sum of 4 quarters · filed 2020-05-11 | |||||
| 2018-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $3.07M derived: sum of 2 quarters · filed 2020-03-09 | $4.59M derived: sum of 3 quarters · filed 2020-03-09 | $6.79M 10-K · filed 2020-03-09 | |||||
| 2018-09-30 | $1.38M 10-Q · filed 2019-11-13 | $2.90M derived: sum of 2 quarters · filed 2019-11-13 | $5.10M 10-Q · filed 2019-11-13 | $7.39M derived: sum of 4 quarters · filed 2019-11-13 | |||||
| 2018-06-30 | $1.52M 10-Q · filed 2019-08-13 | $3.72M 10-Q · filed 2019-08-13 | $6.01M derived: sum of 3 quarters · filed 2019-08-13 | $8.03M derived: sum of 4 quarters · filed 2019-08-13 | |||||
| 2018-03-31 | $2.19M 10-Q · filed 2019-05-13 | $4.49M derived: sum of 2 quarters · filed 2019-05-13 | $6.50M derived: sum of 3 quarters · filed 2019-05-13 | $8.82M derived: sum of 4 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $4.31M derived: sum of 2 quarters · filed 2019-04-01 | $6.63M derived: sum of 3 quarters · filed 2019-04-01 | $9.01M 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | $2.01M 10-Q · filed 2018-11-09 | $4.33M derived: sum of 2 quarters · filed 2018-11-09 | $6.71M 10-Q · filed 2018-11-09 | $8.26M derived: sum of 4 quarters · filed 2018-11-09 | |||||
| 2017-06-30 | $2.31M 10-Q · filed 2018-08-09 | $4.70M 10-Q · filed 2018-08-09 | $6.25M derived: sum of 3 quarters · filed 2018-08-09 | $7.08M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $2.38M 10-Q · filed 2018-05-09 | $3.93M derived: sum of 2 quarters · filed 2018-05-09 | $4.77M derived: sum of 3 quarters · filed 2018-05-09 | $5.41M derived: sum of 4 quarters · filed 2018-05-09 | |||||
| 2016-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $2.38M derived: sum of 2 quarters · filed 2018-03-16 | $3.03M derived: sum of 3 quarters · filed 2018-03-16 | $3.95M 10-K · filed 2018-03-16 | |||||
| 2016-09-30 | $835.31K 10-Q · filed 2017-11-14 | $1.48M derived: sum of 2 quarters · filed 2017-11-14 | $2.40M 10-Q · filed 2017-11-14 | $4.01M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2016-06-30 | $642.58K 10-Q · filed 2017-08-08 | $1.56M 10-Q · filed 2017-08-08 | $3.17M derived: sum of 3 quarters · filed 2018-03-16 | $4.05M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2016-03-31 | $921.71K 10-Q · filed 2017-05-15 | $2.53M derived: sum of 2 quarters · filed 2018-03-16 | $3.41M derived: sum of 3 quarters · filed 2018-03-16 | $4.77M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2015-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $2.49M derived: sum of 2 quarters · filed 2018-03-16 | $3.84M derived: sum of 3 quarters · filed 2018-03-16 | $5.29M 10-K · filed 2018-03-16 | |||||
| 2015-09-30 | $879.20K 10-Q · filed 2016-11-14 | $2.23M derived: sum of 2 quarters · filed 2016-11-14 | $3.68M 10-Q · filed 2016-11-14 | $5.60M derived: sum of 4 quarters · filed 2016-11-14 | |||||
| 2015-06-30 | $1.35M 10-Q · filed 2016-08-15 | $2.80M 10-Q · filed 2016-08-15 | $4.72M derived: sum of 3 quarters · filed 2016-08-15 | $5.79M derived: sum of 4 quarters · filed 2016-08-15 | |||||
| 2015-03-31 | $1.45M 10-Q · filed 2016-05-13 | $3.36M derived: sum of 2 quarters · filed 2016-05-13 | $4.43M derived: sum of 3 quarters · filed 2016-05-13 | $5.55M derived: sum of 4 quarters · filed 2016-05-13 | |||||
| 2014-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $2.98M derived: sum of 2 quarters · filed 2016-03-30 | $4.10M derived: sum of 3 quarters · filed 2016-03-30 | $5.18M 10-K · filed 2016-03-30 | |||||
| 2014-09-30 | $1.07M 10-Q · filed 2015-11-10 | $2.19M derived: sum of 2 quarters · filed 2015-11-10 | $3.26M 10-Q · filed 2015-11-10 | $3.99M derived: sum of 4 quarters · filed 2015-11-10 | |||||
| 2014-06-30 | $1.12M 10-Q · filed 2015-08-13 | $2.19M 10-Q · filed 2015-08-13 | $2.92M derived: sum of 3 quarters · filed 2015-08-13 | $3.66M derived: sum of 4 quarters · filed 2015-08-13 | |||||
| 2014-03-31 | $1.07M 10-Q · filed 2015-05-15 | $1.80M derived: sum of 2 quarters · filed 2015-05-15 | $2.55M derived: sum of 3 quarters · filed 2015-05-15 | $2.79M derived: sum of 4 quarters · filed 2015-05-15 | $2.92M 10-Q · filed 2014-06-06 | ||||
| 2013-12-31 | $726.79K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $1.47M derived: sum of 2 quarters · filed 2015-03-31 | $1.71M derived: sum of 3 quarters · filed 2015-03-31 | $1.76M 10-K · filed 2015-03-31 | |||||
| 2013-09-30 | $745.00K 10-Q · filed 2014-11-14 | $985.11K derived: sum of 2 quarters · filed 2014-11-14 | $1.03M 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | $240.11K 10-Q · filed 2014-08-08 | $289.70K 10-Q · filed 2014-08-08 | |||||||
| 2013-03-31 | $49.59K 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |